Terms: = Kidney tumors AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Prognosis
4 results:
1. Knockdown of ALPK2 blocks development and progression of renal cell carcinoma.
Jiang J; Han P; Qian J; Zhang S; Wang S; Cao Q; Shao P
Exp Cell Res; 2020 Jul; 392(2):112029. PubMed ID: 32330508
[TBL] [Abstract] [Full Text] [Related]
2. MiR-186 represses progression of renal cell cancer by directly targeting cdk6.
Guo Z; Lv X; Jia H
Hum Cell; 2020 Jul; 33(3):759-767. PubMed ID: 32266659
[TBL] [Abstract] [Full Text] [Related]
3. MiR-384 represses tumorigenesis by regulating cdk6 and predicts prognosis of clear cell renal cell carcinoma.
Guo L; Wang D; Zhang Z
J BUON; 2018; 23(3):787-794. PubMed ID: 30003753
[TBL] [Abstract] [Full Text] [Related]
4. High selectivity of PI3Kβ inhibitors in SETD2-mutated renal clear cell carcinoma.
Wang J; Wen J; Yi R; Liu F; Zhou J; Liu G; Li Q; Yang Z; Su X
J BUON; 2015; 20(5):1267-75. PubMed ID: 26537074
[TBL] [Abstract] [Full Text] [Related]
